PCYT2 and metabolic dysfunction-associated steatohepatitis: Our subsequent studies established that the Pcyt2+/– mouse is a model for non-alcoholic steatohepatitis (NASH) and insulin resistance, and that supplementation with phosphoethanolamine helps to reverse NASH symptoms (133).